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Abstract
Background: Primary amoebic meningoencephalitis (PAM) is a rare, often lethal, cause of encephalitis, for which
early diagnosis and prompt initiation of combination antimicrobials may improve clinical outcomes.
Methods: In this study, we sequenced a full draft assembly of the Balamuthia mandrillaris genome (44.2 Mb in size)
from a rare survivor of PAM, and recovered the mitochondrial genome from six additional Balamuthia strains. We
also used unbiased metagenomic next-generation sequencing (NGS) and SURPI bioinformatics analysis to diagnose
an ultimately fatal case of Balamuthia mandrillaris encephalitis in a 15-year-old girl.
Results and Discussion: Comparative analysis of the mitochondrial genome and high-copy number genes from
six additional Balamuthia mandrillaris strains demonstrated remarkable sequence variation, and the closest
Balamuthia homologs corresponded to other amoebae, hydroids, algae, slime molds, and peat moss. Real-time NGS
testing of hospital day 6 CSF and brain biopsy samples detected Balamuthia on the basis of high-quality hits to 16S
and 18S ribosomal RNA sequences present in the National Center for Biotechnology Information (NCBI) nt reference
database. The presumptive diagnosis of PAM by visualization of amoebae on brain biopsy histopathology and NGS
analysis was subsequently confirmed at the US Centers for Disease Control and Prevention (CDC) using a
Balamuthia-specific PCR assay. Retrospective analysis of a day 1 CSF sample revealed that more timely identification
of Balamuthia by metagenomic NGS, potentially resulting in a better clinical outcome, would have required
availability of the complete genome sequence.
Conclusions: These results underscore the diverse evolutionary origins of Balamuthia mandrillaris, provide new
targets for diagnostic assay development, and will facilitate further investigations of the biology and pathogenesis
of this eukaryotic pathogen. The failure to identify PAM from a day 1 sample without a fully sequenced Balamuthia
genome in the database highlights the critical importance of whole-genome reference sequences for microbial
detection by metagenomic NGS.
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Background
Balamuthia mandrillaris is a free-living amoeba that is a
rare, almost uniformly lethal, cause of primary amoebic
meningoencephalitis (PAM) in humans [1]. Originally
isolated from the brain of a baboon at the San Diego
Zoo in 1986, Balamuthia mandrillaris has since been
reported in over 100 cases of PAM worldwide [2–4], and
amoebae associated with fatal encephalitis in a child
have been cultured directly from soil [5]. The vast ma-
jority of cases are fatal, although there are a few pub-
lished case reports of patients surviving Balamuthia
encephalitis after receiving combination antimicrobial
therapy and in vitro data supporting the potential efficacy
of several antimicrobial agents [3, 6–10]. Despite the avail-
ability of validated RT-PCR assays for the detection of free-
living amoebae [11, 12], PAM is not often clinically sus-
pected and the diagnosis is most commonly made around
the time of death or postmortem on brain biopsy [13, 14].
Our lab has demonstrated the capacity of metagenomic
next-generation sequencing (NGS) to provide clinically ac-
tionable information in a number of acute infectious dis-
eases, most notably encephalitis [15, 16]. This approach
enables the rapid and simultaneous detection of viruses,
bacteria, and eukaryotic parasites in clinical samples [17].
Encephalitis is a critical illness with a broad differential,
for which unbiased diagnostic tools such as metagenomic
NGS can make a significant impact [18]. However, the
utility of diagnostic NGS is highly dependent on the
breadth and quality of databases that contain whole-
genome sequence information of reference strains needed
for alignment [19].
In this study, we describe the first draft genome se-
quence of a strain of Balamuthia mandrillaris from a
rare survivor of PAM and comparative sequence ana-
lysis of six additional mitochondrial genomes. We also
demonstrate the ability of metagenomic NGS to rap-
idly detect Balamuthia mandrillaris from the cere-
brospinal fluid (CSF) of a critically ill 15-year-old girl,
and highlight the importance of genomic reference se-




Written informed consent was obtained from the par-
ents of the patient for analysis of her clinical samples,
in accordance with a study approved by the Colorado
Multiple Institutional Review Board (IRB). Written in-
formed consent was also obtained from the parents
for publication of this research. Coded samples from
the patient were analyzed for pathogens by NGS
under study protocols approved by the University of
California, San Francisco IRB.
Metagenomic sequencing of CSF and brain biopsy
Total nucleic acid was extracted from 200 μL of CSF
using the Qiagen EZ1 Viral kit. Half of the nucleic acid
from CSF was treated with Turbo DNase (Ambion).
Total RNA was extracted from 2 mm3 brain biopsy
tissue using the Direct-zol RNA MiniPrep Kit (Zymo Re-
search), followed by mRNA purification using the Oligo-
tex mRNA Mini Kit (Qiagen). Total RNA from CSF and
mRNA from brain biopsy were reverse-transcribed using
random hexamers and randomly amplified as previously
described [20]. The resulting double-stranded cDNA or
extracted DNA from CSF (the fraction not treated with
Turbo DNase) was used as input into Nextera XT, fol-
lowing the manufacturer’s protocol except with reagent
volumes cut in half for each step in the protocol. After
14–18 cycles of PCR amplification, barcoded libraries
were cleaned using Ampure XP beads, quantitated on
the BioAnalyzer (Agilent), and run on the Illumina
MiSeq (1 × 160 bp run). Metagenomic NGS data were
analyzed for pathogens via SURPI using NCBI nt/nr da-
tabases from June 2014 [17].
A rapid taxonomic classification algorithm based on
the lowest common ancestor was incorporated into
SURPI, as previously described [20], and used to assign
viral, bacterial, and non-chordate eukaryotic NGS reads
to the species, genus, or family level. For the SNAP nu-
cleotide aligner [21], an edit distance cutoff of 12 was
used for viral reads [17], but adjusted to a more strin-
gent edit distance of 6 for bacterial and non-chordate
eukaryotic reads to increase specificity.
Rigorous measures were taken to prevent laboratory
contamination and cross-contamination in this study. This
included: (1) library preparation and sequencing of day 1
clinical samples, day 6 samples, and Balamuthia cultures
on different weeks (with at least three sequencing runs in
between to minimize carryover); (2) unidirectional labora-
tory workflow, with separate rooms for the pre-PCR and
post-PCR steps; (3) cleanup of the work area prior to and
after specimen processing with 10 % sodium hypochlorite;
(4) use of disposable gloves and biohazard pouches that
are frequently changed; and (5) dual-index barcoding of
multiplexed clinical samples within individual runs. A
negative control clinical CSF sample from an unrelated
patient was processed in parallel with the case patient’s
CSF and brain biopsy samples at day 1, and was negative
for any reads aligning to Balamuthia. Furthermore, the
nine Balamuthia DNA library sequences observed in the
patient’s day 1 CSF were unique and did not overlap any
of the 926 DNA library sequences in day 6 CSF, excluding
the possibility of amplicon contamination.
Propagation of Balamuthia mandrillaris in culture
Trypsin-treated cultures from Vero or BHK (baby hamster
kidney) cell monolayers and Balamuthia mandrillaris
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amoebas were placed into T25 culture flasks in Dulbecco’s
Modified Eagle Medium (DMEM) plus 10 % bovine
serum, 1 % of the antibiotics 100 U/mL penicillin, 0.1 mg/
mL streptomycin, and 0.25 μg/mL fungizone, and incu-
bated at 37 °C for 7 to 10 days plus 2 days at room
temperature until the underlying cell sheet was completely
destroyed and only actively dividing amebae were seen
floating and/or attached to the surface. Attached amoebas
were freed by gently tapping the side of the flask or put-
ting the flask on a bed of ice for 20 min. The amoebas
were concentrated by centrifugation for 5 min. After re-
moval of supernatant, the amoeba pellet was washed by
addition of PBS, centrifuged again, and then placed in a
flask with Bacto-casitone axenic medium and allowed to
grow for another 7–10 days, after which the amoebas were
concentrated again, washed, and placed into fresh axenic
medium [22]. After a final centrifugation step, the amebae
were collected, washed 3× in PBS, pelleted, and stored at
−80 °C.
Sequencing and annotation of cultured Balamuthia
mandrillaris 2046 strain
DNA from individual strains of Balamuthia mandrillaris
was extracted using the Qiagen EZ1 Tissue Kit and used
as input for the Nextera Mate Pair Kit (Illumina) and Nex-
tera XT Kit (Illumina), following the manufacturer’s in-
structions. Mate-pair libraries were sequenced on an
Illumina MiSeq (2 × 80 nt and 2 × 300 nt runs), while the
Nextera XT library was sequenced on an Illumina HiSeq
(2 × 250 bp paired-end sequencing) (Table 2). Mate-pair
reads from run MP1 were adapter-trimmed with NxTrim
[23], and the mitochondrial genome of strain 2046 and
high-copy number contigs were assembled using SPAdes
v3.5 [24, 25]. The average insert size of the mate-pair li-
brary was 2,187 nucleotides. Prediction of tRNA and
rRNA genes was performed using tRNAscan-SE and
RNAmmer v1.2, respectively [26, 27]. ORFs were pre-
dicted in translation code 4 with the Glimmer gene pre-
dictor, and all predicted ORF sequences were confirmed
using BLASTx and HHPred [28, 29].
Reads from runs MP2 and MP3 were mate-pair
adapter-trimmed using NxTrim, while reads from all
runs were quality-filtered (q30) and adapter-trimmed
using cutadapt [30]. Reads that aligned to the Bala-
muthia mitochondrial genome and golden hamster
(Mesocricetus auratus) were identified using SNAP [21]
and removed prior to de novo assembly using platanus
[31]. Any scaffold of length less than 500 bp along with
62 scaffolds that aligned to Mesocricetus auratus,
Chlorocebus sabaeus, Waddlia chondrophila, and
Enterobacteria phage phiX174 (all likely deriving from
cell culture contamination) were removed.
Rps3 PCR confirmation
Genomic DNA was PCR-amplified using 0.5 μM final
concentration of primers rps3-F (5′-CTGYTCGATTTT
CGAAAAATAAAGTAG-3′) and rps3-R (5′-TGAAA-
GAAGAACATTTAGATCACGACT-3′) using 2X iProof
HF Master Mix (Bio-Rad) in 20 μL total volume. Condi-
tions were 95 °C × 2 min, followed by 35 cycles of 95 °C ×
30 s, 52 °C × 30 s, 72 °C × 40 s, and a final incubation at
72 °C × 2 min. PCR amplicons were visualized by 3 %
agarose gel electrophoresis.
Data access
The Balamuthia mandrillaris mitochondrial genomes have
been deposited in NCBI under the following accession
numbers: 2046 axenic (KP888565), 2046–1 (KT175740),
V451 (KT030670), OK1 (KT030671), RP-5 (KT030672),
SAM (KT030673), V188-axenic (KT175738), V188-frozen
stock (KT175739), and V039 (KT175741). The Balamuthia
mandrillaris scaffolds have been deposited in the NCBI
Whole Genome Shotgun (WGS) database under accession
number LEOU00000000. Metagenomic NGS data corre-
sponding to the patient’s brain biopsy and CSF fluid, as well
as corresponding to a negative control CSF sample from an
unrelated patient, have been submitted to the NCBI Se-
quence Read Archive (SRA) under accession number
SRP064607. NGS reads were filtered for exclusion of hu-
man sequences using Bowtie2 high-sensitivity local align-
ment to the human hg38 reference database at default
parameters followed by BLASTn alignment to all primate
sequences in NCBI nt at an e-value cutoff of 10−8 prior to
deposition into the NCBI SRA database.
Results
First mitochondrial genome of Balamuthia mandrillaris
We cultured Balamuthia mandrillaris strain 2046 in
axenic media from a brain biopsy corresponding to a
rare survivor of PAM (Vollmer and Glaser, manuscript
in review). Sequencing of DNA extracted from the
axenic culture generated 3.8 million 75 base pair (bp)
mate-pair reads with an average insert size of 2,187 bp.
De novo assembly yielded a circular mitochondrial gen-
ome of 41,656 bases that was comprised of 64.8 % AT at
2,082× coverage (Fig. 1a). The overall size and AT con-
tent of the Balamuthia mandrillaris mitochondrial gen-
ome was closer to that of Acanthamoeba castellani
(41,591 bp, 70.6 % AT) [32] than Naegleria fowleri
(49,531 bp, 74.8 % AT) [33], although overall average
nucleotide identity with Balamuthia was found to be
low for both amoebae (approximately 68 %).
The Balamuthia mandrillaris 2046 mitochondrial
genome contained two ribosomal RNA (rRNA) genes,
18 transfer RNA (tRNA) genes, and 38 coding se-
quences, with five of those being hypothetical proteins.
The organization of the mitochondrial genome retained
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several syntenic blocks with the Acanthamoeba castel-
lani genome, including tnad3-9-7-atp6 and rpl11-rps12-
rps7-rpl2-rps19-rps3-rpl16-rpl14. However, many other
features of the genome were unique, such as the order
of the remaining coding blocks, the lack of a combined
cox1/cox2 gene, as present in Acanthamoeba castellani
[32], and the lack of intron splicing in 23S rRNA. The
Balamuthia mandrillaris mitochondrial cox1 gene was
interrupted by a LAGLIDADG endonuclease open read-
ing frame (ORF) containing a group I intron, as has been
reported for a wide variety of other eukaryotic species
[34, 35]. The putative rps3 gene was encoded within a
1,290 bp ORF that, when translated, aligned by hidden
Markov model (HMM) analysis to rps3 proteins from
Escherichia coli (PDB 4TP8/4U26) and Thermus thermo-
philus (PDB 4RB5/4W2F), and only in base positions 1–
66 and 583–1290 of the ORF. This finding was consist-
ent with the presence of a putative > 500 bp intron in
the Balamuthia mandrillaris rps3 gene that to date has
only been described to in plants [36, 37]. Alternatively,
the ORF was also found to encode a putative tRNA
(Asn) such that the 5′ end of the ORF could represent a
large intergenic sequence.
Mitochondrial genome diversity of Balamuthia mandrillaris
To investigate the extent of sequence diversity in Bala-
muthia mandrillaris, we sequenced the mitochondrial ge-
nomes from six additional Balamuthia strains obtained
from the California Department of Public Health and
the American Tissue Culture Collection (Table 1).
The seven total circular mitochondrial genomes aver-
aged 41,526 bp in size (range, 39,996 to 42,217 bp), and
shared pairwise nucleotide identities in the range of
82.6 % to 99.8 %. The phylogeny revealed the presence
of at least three separate lineages of Balamuthia man-
drillaris, with all four strains from human cases in
California clustering together in a single clade (Table 1;
Fig. 1b). Consistent with a previous report [38], we
found that the mitochondrial genome of strain V451
was the most divergent among tested strains, and pos-
sessed an additional 1,149 bp ORF downstream of the
cox1 gene that did not align significantly to any sequence
in the NCBI nt or nr reference database. Of note, our
V039 mitochondrial genome assembly showed > 99.9 %
identity to a recently deposited PacBio / Illumina assembly
of the V039 mitochondrial genome. The only difference
between the two mitochondrial genomes was a 102-bp in-
sertion that was located in the unique rps3 locus [39].
Putative introns constituted the major source of vari-
ation among the mitochondrial genomes (Fig. 1c). Four
strains out of seven, including strain 2046 from the rare
survivor of Balamuthia infection, contained a 975 bp
LAGLIDADG-containing intron in the cox1 gene, whereas
no such intron was present in the remaining three strains.
Two of the remaining three strains, strains V451 and
V188, instead had an approximately 790 bp insert in
the 23S rRNA gene (Fig. 1a, ‘rnl RNA’) that contained a
530 bp or 666 bp LAGLIDADG-containing ORF,
Table 1 Strains used in this study
Strain Date Location Note Citation
SAMa Spring 2001 California 3-year-old girl, cultured on Vero cells Bakardjiev A et al., 2002 [55]
RP-5a Spring 2001 California Environmental sample associated with SAm, cultured on Vero cells Schuster FL et al., 2003 [5]
OK1a 2002 California Environmental sample in NorCal unrelated to SAm, cultured on Vero cells Dunnebacke TH et al., 2004 [56]
V039b 1990 California Type strain isolated from pregnant mandrill at San Diego Zoo, cultured
on Vero cells
Visvesvara GS et al., 1990 [4]
V188a 1989 Georgia 59-year-old man, amoeba isolated from brain/skin lesion, cultured on Vero cells Gordon SM et al., 1992 [57]
V451a - New York 6-year-old girl, cultured on Vero cells Yang XH et al., 2001 [58]
2046a March 2010 California 26-year-old man, survivor, cultured on Vero cells Vollmer and Glaser, in review
CSF108c May 2015 Colorado 15-year-old girl, direct metagenomic detection from CSF
aStrain provided by Dr. Dunnebacke at the California Department of Public Health
bStrain obtained from ATCC (V39)
cStrain obtained from recent clinical case in Colorado
(See figure on previous page.)
Fig. 1 Sequencing and comparative phylogenetic analysis of the mitochondrial genome of Balamuthia mandrillaris. a Balamuthia mandrillaris
2046 mitochondrial genome. Annotation of the 41,656 bp genome was performed using RNAmmer, tRNAscan-SE, and Glimmer gene predictor,
with all ORFs manually verified using BLASTx alignment. b Phylogenetic analysis of seven newly sequenced mitochondrial genomes from different
strains of Balamuthia mandrillaris. An outgroup (for example, Acanthamoeba castellani) is not shown given the lack of gene synteny. Branch
lengths are drawn proportionally to the number of nucleotide substitutions per position, and support values are shown for each node. c Differences in
individual gene features (cox1, 23S rRNA, and rps3), among the 7 mitochondrial genomes, as detailed in the text. The mitochondrial cox1, 23S rRNA /
rnl RNA, and rps3 genes are highlighted in boldface
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respectively, and that coded for a putative endonucle-
ase. The LAGLIGDADG-containing endonucleases in
the two strains shared 84 % amino acid pairwise iden-
tity with each other, but approximately 50 % amino acid
identity to a corresponding LAGLIGDADG-containing
endonuclease in the 23S rRNA gene of Acanthamoeba
castellani, and < 12 % amino acid identity to the
LADGLIDADG-containing cox1 introns in the four other
Balamuthia strains. The final remaining strain, ATCC-V039,
lacked an intron in either the cox1 or 23S rRNA gene.
The ORF containing the rps3 gene, found to contain a
possible rps3 intron / intergenic region by analysis of the
strain 2046 mitochondrial genome, varied in length
among the seven sequenced mitochondrial genomes
from 1,290 bp to 1,425 bp. Notably, the length of the
putative intron / intergenic region accounted for all of
the differences in overall length of the rps3 gene. Con-
firmatory PCR and sequencing of this locus using con-
served outside primers revealed that each strain tested
had a unique length and sequence (Fig. 2), raising the
possibility of targeting this region for Balamuthia man-
drillaris strain detection and genotyping.
First draft genome of Balamuthia mandrillaris
Because of the high-copy number of mitochondrial
sequences in the Balamuthia sequencing run, as noted pre-
viously for Naegleria fowleri [33], we performed an add-
itional NGS run of 14.1 million 250 bp single-end reads,
and computationally subtracted reads aligning to the mito-
chondrial genome. Assembly of the remaining 4.4 million
high-quality reads yielded 31,194 contiguous sequences
(contigs) with an N50 of 3,411 bp. Scaffolding and gap
closure using an additional 57.4 million NGS reads and
computational removal of exogenous sequence contami-
nants yielded a final assembly of approximately 44.3 Mb
comprising 14,699 scaffolds with an N50 of 19,012 bp
(Table 2). Direct BLASTn alignment of the scaffolds to
the National Center for Biotechnology Information
(NCBI) nt database revealed that the most common or-
ganism aligning to Balamuthia mandrillaris was Mus
musculus (house mouse) (2,067/14,699 = 14.1 % of scaf-
folds), nearly entirely due to low-complexity sequences,
followed by high-significance hits to Acanthamoeba
castellani (627/14,699 = 4.3 % of scaffolds).
Phylogentic analysis of individual genes from the Bala-
muthia mitochondrial genome revealed the presence of sig-
nificant diversity across all kingdoms of life (Fig. 3). The
18S-28S rRNA locus in the Balamuthia mitochondrial gen-
ome corresponded to a 12.5 kB contig sequenced at high
coverage (> 400 × over rRNA regions). The previously se-
quenced 18S gene (2,017 bp) demonstrated 99.5 % identity
to existing Balamuthia mandrillaris 18S rRNA sequences
in the NCBI nt database, while the 28S gene (4,999 bp) had
homology across multiple diverse species, with only 68.5 %
pairwise identity to its closest phylogenetic relative, Acanth-
amoeba castellani (Fig. 3b). From the nuclear genome, one
high-copy contig contained a truncated 5,250 nucleotide
ORF exhibiting only 33 % amino acid identity to Rhizopus
delemar (pin mold), and harboring elements consistent with
a retrotransposon [40], including an RNAse HI from Ty3/
Gypsy family retroelements, a reverse transcriptase, a
chromodomain, and a retropepsin. Two high-copy, ap-
proximately 1,600 bp ORFs that failed to match any se-
quence by BLASTx alignment to the NCBI nr protein
database were found to align significantly to Escherichia
coli site-specific recombinase by remote homology HMM
analysis.
A case of Balamuthia encephalitis diagnosed by
metagenomic NGS
Concurrent with assembly of the Balamuthia genome,
metagenomic NGS was performed to investigate a case
of meningoencephalitis in a 15-year-old girl with insulin-
Fig. 2 PCR amplification of the Balamuthia rps3 mitochondrial gene. The variable length of the rps3 intron among eight different Balamuthia
strains (seven newly sequenced mitochondrial genomes and the case patient) suggests that this gene may be an attractive target for development of
a molecular genotyping assay. Lane 8 corresponds to the DNA ladder (faint appearance), while lanes 3 and 4 correspond to an additional clinical
Balamuthia isolate whose mitochondrial genome was not sequenced
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dependent diabetes mellitus and celiac disease. The pa-
tient initially presented to a community emergency room
with 7 days of progressive symptoms including right arm
weakness, headache, vomiting, ataxia, and confusion. Her
diabetes was well controlled with an insulin pump, and
she did not take any additional medications. Exposure his-
tory was significant for contact with alpacas at a family
farm and swimming in a freshwater pond 9 months prior.
She had no international travel, sick contacts, or insect
bites. She was given 10 mg dexamethasone with symp-
tomatic improvement in her headaches, but was subse-
quently transferred to a tertiary care children’s hospital
after a computed tomography (CT) scan revealed left oc-
cipital and frontal hypodensities.
On HD 1, peripheral white blood count was 11.6 × 103
cells/μL (89 % neutrophils, 6 % lymphocytes, 4 % mono-
cytes), erythrocyte sedimentation rate was 13 mm/h
(normal range, 0–20 mm/h), C-reactive protein was
3 mg/dL (normal range, 0–1 mg/dL), and procalcitonin
0.05 ng/mL (normal range, 0–0.5 ng/mL). CSF analysis
demonstrated 377 leukocytes/μL (2 % neutrophils, 53 %
lymphocytes, 39 % monocytes, and 6 % eosinophils),
glucose of 122 mg/dL (normal range, 40–75 mg/dL),
and protein of 59 mg/dL (normal range, 12–60 mg/dL).
Viral polymerase chain reaction (PCR) testing for her-
pes simplex virus (HSV) and bacterial cultures were
negative. Magnetic resonance imaging (MRI) scan of the
brain on HD 1 showed hemorrhagic lesions with sur-
rounding edema in the superior left frontal lobe and left
occipital lobe with a small focus of edema in the right
cerebellum (Fig. 4a).
Given the patient’s autoimmune predisposition and
hemorrhagic appearance of the brain lesions, acute
hemorrhagic leukoencephalitis, an autoimmune disease,
was initially suspected and intravenous methylprenisolone
(1,000 mg daily) was given HD 2–5. The patient clin-
ically deteriorated with worsening headache, increas-
ing weakness, and altered mental status on HD 5.
Repeat MRI on HD 5 demonstrated enlargement of
the previous hemorrhagic lesions with interval devel-
opment of multiple rim-enhancing lesions (Fig. 4b).
Steroids were discontinued and broad-spectrum anti-
microbial therapy with vancomycin, cefotaxime, metro-
nidazole, amphotericin B, voriconazole, and acyclovir
was initiated. On HD 6, she underwent craniotomy for
brain biopsy, revealing partially necrotic white matter,
and had an external ventricular drain placed. CSF wet
mount and gram stain, bacterial and fungal cultures,
PCR testing for HSV and varicella-zoster virus (VZV),
and oligoclonal bands were negative. Pathology of the
brain biopsy sample showed a hemorrhagic necrotizing
process with neutrophils, tissue necrosis, vasculitis, and
numerous amoebae. She was additionally started on
azithromycin, sulfadizine, pentamidine, and flucytosine
on HD 7. On HD 8, she developed intracranial hyper-
tension, cardiac arrest and died. Miltefosine had been
requested and was en route from the CDC [3, 9, 41];
however this medication did not arrive in time to ad-
minister before the patient died. Parallel metagenomic
NGS testing of CSF and brain biopsy samples around
the time of death confirmed the presence of sequences
from Balamuthia mandrillaris (see below). Autopsy
was not performed according to the wishes of the fam-
ily. Subsequent clinical laboratory testing of the brain
biopsy sample at the US Centers for Disease Control
and Prevention (CDC), using a specific PCR targeting
the RNAse P gene [42], confirmed the diagnosis of
Balamuthia mandrillaris encephalitis.
Table 2 Sequencing runs and genome assembly details
Sequencing run Raw reads Filtered reads Read length Library prep
MP1a 3845734 N/A 2 × 80 bp Nextera Mate-Pair
MP2a 31223454 12095792 2 × 80 bp Nextera Mate-Pair
MP3a 14121900 4397510 2 × 250 bp Nextera Mate-Pair
PE1b 213604902 29314946 2 × 250 bp Nextera XT
Genome Assemblyc Contigs N50 (bp) Assembly Size
Mitochondria 1 41,656 41,656
Contigs 31,194 3,411 48,938,887
Scaffolds 26,811 19,415 49,120,517
Gap-fill 26,811 19,012 48,939,625
Final assembly (minus <500 bp, contaminants) 14,699 26,144 44,270,879
aThree runs of a Nextera mate-pair library of Balamuthia strain 2046 from axenic culture sequenced on an Illumina MiSeq
bNextera XT paired-end library of strain 2046 sequenced on an Illumina HiSeq
cAssembly of mitochondrial genome from MP1 library, of whole-genome from all four libraries
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Identification of Balamuthia in CSF and brain biopsy
material
Metagenomic NGS and SURPI bioinformatics analysis
were used to analyze the patient’s HD 6 CSF and brain
biopsy for potential pathogens. Analysis of the viral por-
tion of RNA or DNA derived reads revealed only phages
or misannotated sequences (Additional file 1: Table S1),
while most of the bacterial reads mapped to common
skin / environmental contaminants such as Propionibac-
terium and Staphylococcaceae in the HD 6 CSF RNA
library. In contrast, a total of 22,506 reads aligned to
Balamuthia (Fig. 5a and 5b), of which 20,145 were
taxonomically assigned to Balamuthia mandrillaris
(Additional file 1: Table S1). These 20,145 reads com-
prised 79 % of all species-level non-chordate (lacking a
backbone) eukaryotic reads in the HD 6 CSF dataset,
and mapped to available 16S and 18S sequences of
Balamuthia mandrillaris in the NCBI nt reference data-
base [38]. A minority of the non-chordate eukaryotic
reads aligned to Acathamoeba spp. (145 reads). Reads to
Balamuthia were also detected in the DNA (13 reads)
and brain biopsy RNA libraries (9 reads). The coverage
of the 16S rRNA gene in the RNA library was sufficiently
high to assemble a 1,405 bp full-length contig sharing
99.9 % identity with the 2046 strain of Balamuthia. In the
18S locus, mapped NGS reads from the patient spanned
98.1 % of the gene and were 99.1 % identical by nucleo-
tide. No NGS hits were detected to the RNAse P gene, the
only additional Balamuthia gene represented in the NCBI
nt reference database as of August 2015.
We then sought to determine in retrospect whether
earlier detection and diagnosis of Balamuthia infection
in the case patient by NGS would have been feasible.
Metagenomic NGS of a day 1 CSF sample followed by
SURPI analysis using the June 2014 NCBI nt reference
database generated no sequence hits to Balamuthia
(Fig. 5b; Additional file 1: Table S1). However, repeating
the analysis after adding the draft genome sequence of
Balamuthia mandrillaris to the reference database re-
sulted in the detection of additional Balamuthia reads
(Fig. 5b and c) Importantly, nine species-specific DNA
reads were detected from day 1 CSF (Fig. 5b, red text;
Table 3). Although only two of nine putative Bala-
muthia reads had identifiable translated nucleotide
identity to any protein in the NCBI nr database, one of
those reads was found to share 77 % amino acid iden-
tity to the gluathione transferase protein from
Acanthamoeba castellani, and hence most likely repre-
sented a bona fide hit to Balamuthia. These findings
also indicated that the detection of Balamuthia reads
was not due to errors in the draft genome assembly
from incorporation of contaminating sequences from
other organisms. Thus, detection of Balamuthia from
the patient’s day 1 sample and a more timely diagnosis
by metagenomic NGS would presumably not have
been made without the availability of the full draft
genome as part of the reference database used for
alignment.
Discussion
In this study, we describe a ‘virtuous cycle’ of clinical se-
quencing in which the continually increasing breadth of
microbial sequences in reference databases improves the
sensitivity and accuracy of infectious disease diagnosis,
in turn driving the sequencing of additional reference
strains. The assembly of the first draft reference genome
for Balamuthia not only enhances the potential sensitiv-
ity of metagenomic NGS for detecting this pathogen, as
shown here, but also provides new target sequences such
as the rps3 intron / intergenic region and 28S rRNA
gene that can be leveraged for the future development of
more sensitive and specific diagnostic assays. Given the
lack of proven efficacious treatments for Balamuthia
encephalitis, it is unclear whether even earlier diagnosis
at HD 1 would have impacted the fulminant course of
our case patient’s infection. However, it has been sug-
gested that timely intervention in cases of Balamuthia
might lead to improved outcome [43]. In addition,
promising new experimental treatments such as milte-
fosine [3, 9, 41], administered to the survivor infected
by the sequenced 2046 strain (Vollmer and Glaser,
under review), are now available.
Unbiased metagenomic NGS is a powerful approach
for diagnosis of infectious disease because it does not
rely on the use of targeted primers and probes, but ra-
ther, detects any and all pathogens on the basis of
uniquely identifying sequence information [44]. Rapid
and accurate bioinformatics algorithms [21, 45–47] and
computational pipelines [17] have also been developed,
with the capacity to analyze metagenomic NGS data in
clinically actionable time frames. We also demonstrate
here the critical role of comprehensive reference genomes
in the NGS diagnostic paradigm. The availability of patho-
gen genomes with coverage of all clinically relevant
(See figure on previous page.)
Fig. 3 Phylogenetic trees of the mitochondrial cox1 protein and 28S rRNA gene reveal the close phylogenetic relationship between Balamuthia
and Acanthamoeba. a Phylogeny of seven Balamuthia cox1 amino acid sequences along with the top complete sequence hits in NCBI nr ranked
by BLASTp E-score. b Phylogeny of seven Balamuthia 23S rRNA nucleotide sequences along with the top complete sequence hits in NCBI nt
ranked by BLASTn E-score. Sequences were aligned using MUSCLE and a phylogenetic tree constructed using MrBayes. Branch lengths are drawn
proportionally to the number of nucleotide substitutions per position, and support values are shown for each node
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genotypes can maximize the utility of NGS for not only
diagnosis of individual patients [15, 16], but also public
health applications such as transmission dynamics [48] and
outbreak investigation [20, 49]. Current limitations of meta-
genomic NGS for routine infectious disease diagnosis in-
clude: (1) the need to analyze millions of sequences in
clinically actionable timeframes of minutes to hours (which
has been at least partially addressed by rapid computational
pipelines such as SURPI) [17]; (2) challenges in discriminat-
ing true pathogens from host flora or laboratory reagent
contaminants in NGS data [50, 51]; and (3) regulatory is-
sues concerning validation of an assay targeting a poten-
tially unlimited number of pathogens.
However, a key advantage of metagenomic NGS is that
it does not rely on a priori suspicion of the etiology of the
infectious agent. In our case patient, PAM was not clinic-
ally suspected, so specific PCR testing for Balamuthia was
not done. Similarly, in another reported case of a women
with endophthalmitis followed by meningoencephalitis
[52], PAM also was not clinically suspected, requiring
Fig. 4 MRI and histopathology from a 15-year-old patient with a fulminant acute encephalitis. a A hospital day (HD) 1 coronal T2-weighted
MR image, demonstrating a hemorrhagic lesion with surrounding edema within the superior left frontal lobe (left panel, white arrow) and left
occipital lobe (right panel, white arrow). b A HD 5 contrast-enhanced T1-weighted MR image, revealing enlargement of the pre-existing left
frontal lobe lesion (left panel, white arrow), as well as interval development of numerous additional rim-enhancing lesions in multiple regions
(right panel, white arrows). c 20× (left and right panels) and 100× fields of view (right panel, inset) of a brain biopsy specimen from the patient
demonstrating numerous viable, large amoebae (black arrows), with abundant basophilic vacuolated cytoplasm, round central nuclei, and prominent
nucleoli, consistent with Balamuthia mandrillaris. There were areas of extensive hemorrhagic necrosis accompanied by a polymorphic inflammatory cell
infiltrate including neutrophils and eosinophils (right panel)
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Fig. 5 (See legend on next page.)
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metagenomic NGS for diagnosis. Although broad-range
PCR assays targeting the conserved bacterial 16S rRNA
gene and eukaryotic 18S rRNA gene are available in select
reference laboratories, there have been some concerns
raised regarding sensitivity [53]. In addition, it is highly un-
likely that 18S PCR sequencing would have been positive in
the patient’s day 1 CSF given the absence of Balamuthia
18S sequences in the case patient's metagenomic NGS data
(Fig. 5b).
In the field of amoebic encephalitis, draft genomes are
now available for Acanthamoeba castellani [32], Naegle-
ria fowleri [54], and Balamuthia mandrillaris. However,
more sequencing is certainly necessary to better under-
stand the genetic diversity of these eukaryotic patho-
gens. In particular, shotgun sequencing and comparative
analysis of mitochondrial genomes from seven Bala-
muthia strains uncovered at least three unique lineages,
one of which was comprised entirely of amoebae iso-
lated from California, revealing that geographic differ-
ences likely exist among strains (Fig. 1b). This study
also identified a unique locus in a putative rps3 intron /
intergenic region of the mitochondrial genome that is
an attractive target for a clinical genotyping assay
(Figs. 1c and 2). Given the rarity of the disease, it is un-
known whether infection by different strains of Bala-
muthia would affect clinical course or outcome,
although the future availability of routine genotyping as-
says could help in addressing this question.
Limitations to this study include the small number of
accessible clinical samples of Balamuthia mandrillaris
infection and assembly of a draft genome with > 14,000
scaffolds as a result of restricting the sequencing to short
reads. Notably, an independently assembled draft gen-
ome of Balamuthia mandrillaris, comprising only 1,605
total contigs as a result of leveraging both long-read
(PacBio) and short read (Illumina) technologies, has re-
cently been published [39]. Additional messenger RNA
(mRNA) sequencing of Balamuthia will still be needed
to predict transcripts, identify splice junctions, and fa-
cilitate complete annotation of the genome.
Conclusions
We demonstrate here that the availability of pathogen ref-
erence genomes is critical for the sensitivity and success of
unbiased metagenomic next-generation sequencing ap-
proaches in diagnosing infectious disease. In hindsight,
Table 3 Balamuthia mandrillaris reads from the day 1 patient sample
Read
no.












1 None − − scaffold46 96 % 5.00E-29
2 None − − scaffold26764 96 % 3.00E-27
3 None − − scaffold45 100 % 3.00E-36





scaffold203 100 % 3.00E-36
6 None − − scaffold106 96 % 1.00E-26
7 Glutathione transferase protein
(Acanthoamoeba castellani str. Neff)
77 % 0.022 scaffold30 99 % 8.00E-34
8 None − − scaffold112 97 % 7.00E-28
9 None − − scaffold511 98 % 5.00E-26
(See figure on previous page.)
Fig. 5 Identification of Balamuthia mandrillaris infection by metagenomic next-generation sequencing (NGS). a Coverage maps (blue gradient)
and pairwise identity plots (magenta gradient) of two of the three available sequences from Balamuthia (16S/18S rRNA genes) in the NCBI nt
reference database as of August 2015. Shown are coverage maps corresponding to day 6 DNA and RNA libraries from CSF and a day 6 mRNA li-
brary from brain biopsy. No hits to 16S and 18S Balamuthia sequences were seen from day 1 samples. The asterisk denotes an area with artificially
low coverage after taxonomic classification of the NGS reads due to high conservation among eukaryotic sequences (for example, human, Bala-
muthia, and so on) within that region. b A bar graph of the number of species-specific NGS reads aligning to Balamuthia 16S/18S rRNA (blue) or
the Balamuthia genome (orange) in day 1 or day 6 samples. Note that with the availability of the newly assembled 44 Mb Balamuthia genome,
diagnosis of Balamuthia mandrillaris encephalitis at day 1 would have possible by detection of nine species-specific reads (red boldface). c Cover-
age maps of two large scaffolds, approximately 216 kB and 222 kB in size, from the Balamuthia draft genome, showing eight out of 926 hits to
Balamuthia in the day 6 CSF DNA library that are identified by SURPI after the draft genome sequence is added to the reference database (versus
only 13 hits previously)
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more timely and potentially actionable diagnosis at hos-
pital day 1 in a fatal case of PAM from Balamuthia man-
drillaris would have required the availability of the full
genome sequence. Thus, in addition to revealing a sig-
nificant amount of evolutionary diversity, the draft gen-
ome of Balamuthia mandrillaris presented here will
improve the sensitivity of sequencing-based efforts for
diagnosis and surveillance, and can be used to guide
the development of targeted assays for genotyping and
detection. The draft genome also constitutes a valuable
resource for future studies investigating the biology of
this eukaryotic pathogen and its etiologic role in PAM.
Additional file
Additional file 1: Table S1. SURPI clinical metagenomic results
(XLSX 390 kb)
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